Novavax

Novavax NVAX Stock

$10.34   0.193803%
Add to favorites
Market Cap
$1.71B
LOW - HIGH [24H]
$9.90 - $10.48
VOLUME [24H]
$6.21M
P/E Ratio
0
Earnings per share
-$1.53
ISIN
US6700024010
Price   Prediction

Novavax Price Chart

Sorry, that's all we've gotfor now...

Novavax NVAX Financial and Trading Overview

Novavax stock price 10.34 USD
Previous Close 10.32 USD
Open 10.42 USD
Bid 9.4 USD x 100
Ask 12.71 USD x 100
Day's Range 9.9 - 10.48 USD
52 Week Range 6.2 - 11.97 USD
Volume 5.21M USD
Avg. Volume 4.26M USD
Market Cap 1.71B USD
Beta (5Y Monthly) 2.416
PE Ratio (TTM) N/A
EPS (TTM) -1.53 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 14 USD

NVAX Valuation Measures

Enterprise Value 1.28B USD
Trailing P/E N/A
Forward P/E -16.84286
PEG Ratio (5 yr expected) 1.32
Price/Sales (ttm) 4.12169
Price/Book (mrq) N/A
Enterprise Value/Revenue 3.094
Enterprise Value/EBITDA -12.607

Trading Information

Novavax Stock Price History

Beta (5Y Monthly) 2.416
52-Week Change 32.47%
S&P500 52-Week Change 17.90%
52 Week High 11.97 USD
52 Week Low 6.2 USD
50-Day Moving Average 8.52 USD
200-Day Moving Average 8.52 USD

NVAX Share Statistics

Avg. Volume (3 month) 4.26M USD
Avg. Daily Volume (10-Days) 6.32M USD
Shares Outstanding 164.95M
Float 142.52M
Short Ratio 15.44
% Held by Insiders 5.06%
% Held by Institutions 68.83%
Shares Short 47.49M
Short % of Float 28.98%
Short % of Shares Outstanding 28.78%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:20

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -59.86%
Operating Margin (ttm) -89.60%
Gross Margin -2.55%
EBITDA Margin -24.54%

Management Effectiveness

Return on Assets (ttm) -6.51%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 413.8M USD
Revenue Per Share (ttm) 2.54 USD
Quarterly Revenue Growth (yoy) -76.29%
Gross Profit (ttm) -10583000 USD
EBITDA -101552000 USD
Net Income Avi to Common (ttm) -247730000 USD
Diluted EPS (ttm) -1.53
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 719.34M USD
Total Cash Per Share (mrq) 4.36 USD
Total Debt (mrq) 297.32M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 2.333
Book Value Per Share (mrq) -1.157

Cash Flow Statement

Operating Cash Flow (ttm) -36901000 USD
Levered Free Cash Flow (ttm) 153.39M USD

Profile of Novavax

Country United States
State MD
City Gaithersburg
Address 21 Firstfield Road
ZIP 20878
Phone 240 268 2000
Website https://www.novavax.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 749

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Q&A For Novavax Stock

What is a current NVAX stock price?

Novavax NVAX stock price today per share is 10.34 USD.

How to purchase Novavax stock?

You can buy NVAX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Novavax?

The stock symbol or ticker of Novavax is NVAX.

Which industry does the Novavax company belong to?

The Novavax industry is Biotechnology.

How many shares does Novavax have in circulation?

The max supply of Novavax shares is 164.95M.

What is Novavax Price to Earnings Ratio (PE Ratio)?

Novavax PE Ratio is now.

What was Novavax earnings per share over the trailing 12 months (TTM)?

Novavax EPS is -1.53 USD over the trailing 12 months.

Which sector does the Novavax company belong to?

The Novavax sector is Healthcare.

Novavax NVAX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 26584.06 USD
+1.4
6.52B USD 26325.06 USD 26644.57 USD 6.52B USD
us Dow Jones U.S. Biotechnology In DJUSBT US 3686.68 USD
+0.26
93.22M USD 3638.81 USD 3702.94 USD 93.22M USD
us US Tech Composite Total Return XCMP US 32818.26 USD
+1.4
32498.54 USD 32892.96 USD
us US Tech Next Generation 100 Inde NGX US 1834.63 USD
+0.99
1816.74 USD 1834.72 USD
us US Tech Biotechnology NBI US 7293.85 USD
+0.09
7216.75 USD 7313.92 USD
us US Tech Health Care IXHC US 1364.52 USD
+0.09
1351.47 USD 1370.41 USD
us US Tech Biotechnology Total Retu XNBI US 7966.12 USD
+0.09
7881.91 USD 7988.04 USD
us US Tech Global Select Market Com NQGS US 13060 USD
+1.41
12930.02 USD 13090.58 USD
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD
-1.26
3927.42 USD 4148.65 USD
$2.68T
Total marketcap
$120.77B
Total volume
BTC 59.15%     ETH 11.10%
Dominance
Select currency